TipRanks
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
14Bullish
3Neutral
5Bearish
Oscillators
Sell
2Bullish
3Neutral
5Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.65, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 26.83, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 25.49, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Sep 25, 2026, 08:05 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.99
28.07
27.99
28.07
27.99
28.07
27.99
Fibonacci
28.07
28.07
28.07
28.07
28.07
28.07
28.07

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Sep 25, 2026, 08:05 PM
Period
Simple
Exponential
MA5
27.70Buy
27.67Buy
MA10
27.04Buy
27.31Buy
MA20
26.92Buy
26.83Buy
MA50
25.11Buy
25.49Buy
MA100
23.17Buy
24.07Buy
MA200
22.32Buy
23.09Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 27.31, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 24.07, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 25.11, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 23.17, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 22.32, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Sep 25, 2026, 08:05 PM
Name
Value
Action
RSI (14)
67.14
Neutral
STOCH (9,6)
92.30
Sell
STOCHRSI (14)
93.15
Sell
MACD (12,26)
0.65
Sell
ADX (14)
23.77
Neutral
Williams %R
-10.75
Sell
CCI (14)
109.91
Sell
ATR (14)
0.28
-
Ultimate Oscillator
67.55
Neutral
ROC
3.60
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 67.14, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 23.77, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 109.91, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 3.60, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 67.14, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.65, which suggests CURE is a Sell.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 27.70, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 26.92, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 25.11, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 22.32, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -10.75, which suggests CURE is a Sell.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 109.91, which suggests CURE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement